12 Marijuana Stocks to Buy Now in 2018

There are now more than 50 publicly-traded companies operating in the cannabis industry. Most of these companies aren't directly growing and selling marijuana themselves, but they do stand to benefit greatly as more states legalize the sale and possession of marijuana. Some of these marijuana stocks are media companies. Others are privately studying the medical uses of marijuana. Yet others are providing tools and software for marijuana growers. As more cannabis companies file IPOs and enter the stock market, it will become increasingly difficult for investors to identify which marijuana stocks will truly benefit from the cannabis boom.

Our subscribers have begun digging through these companies, checking out their financials, business models and long-term growth prospects. They know that some "marijuana stocks" are just empty shell companies that deserve to be penny stocks, but they also recognize there are some legitimate and growing companies that truly stand to benefit from the green rush. As a group, they have added 10 different cannabis stocks to their watchlists and are actively investing in them. More than 1,400 MarketBeat subscribers are now following our top-trending cannabis company.

This slide show lists the 12 pot stocks that MarketBeat subscribers are have added to their watchlists and are actively monitoring.

#1 - Canopy Growth (NYSE:CGC)

MarketBeat Followers: 2,492
Market Cap: $6.85 billion
Consensus Rating: Buy
Rating Score: 2.5
Ratings Breakdown: 1 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $15.00 (-57.0% Upside)

Canopy Growth Corporation, through its subsidiaries, produces and sells medical marijuana in Canada. The company offers dried, oil, and softgel cannabis products. Canopy Growth Corporation also sells its products through online. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

#2 - Canopy Growth (TSE:WEED)

MarketBeat Followers: 1,361
Market Cap: C$6.35 billion
Consensus Rating: Buy
Rating Score: 2.7
Ratings Breakdown: 1 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: C$27.50 (-41.2% Upside)

Canopy Growth Corporation, through its subsidiaries, produces and sells medical marijuana in Canada. The company offers dried, oil, and softgel cannabis products. Canopy Growth Corporation also sells its products through online. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

#3 - Terra Tech (OTCMKTS:TRTC)

MarketBeat Followers: 963
Market Cap: $195.48 million
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

Terra Tech Corp. operates as a vertically integrated cannabis-focused agriculture company. The company operates in two segments, Herbs and Produce Products; and Cannabis Dispensary, Cultivation and Production. The Herbs and Produce Products segment offers hydroponic herbs, produce, and floral products. The Cannabis Dispensary, Cultivation and Production segment operates medical marijuana retail and adult use dispensaries under the name Blüm, which provides a selection of medical and adult use cannabis products, such as flowers, concentrates, and edibles; and produces and sells a line of medical and adult use cannabis flowers, as well as a line of medical and adult use cannabis-extracted products comprising concentrates, cartridges, vape pens, and wax products in California and Nevada. Terra Tech Corp. was founded in 2010 and is headquartered in Irvine, California.

#4 - 22nd Century Group (NYSEAMERICAN:XXII)

MarketBeat Followers: 745
Market Cap: $316.82 million
Consensus Rating: Buy
Rating Score: 3.0
Ratings Breakdown: 1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $11.50 (434.9% Upside)

22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.

#5 - Cannabis Science (OTCMKTS:CBIS)

MarketBeat Followers: 720
Market Cap: $190.59 million
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

Cannabis Science, Inc., together with its subsidiaries, develops, produces, and commercializes phytocannabinoid-based pharmaceutical products primarily in the United States. The company is developing medicines for autism, blood pressure, cancer, cancer side effects, and other illnesses, as well as for general health maintenance. Its drugs under development include CS-TATI-1 for newly diagnosed and treatment-experienced patients with drug-resistant HIV strains, as well as those intolerant of available therapies; CS-S/BCC-1 to treat basal and squamous cell carcinomas; and a proprietary cannabis-based therapy for neurological conditions. In addition, the company offers an online video-based medical cannabis education system, including courses, such as medical cannabis law, benefits of medical marijuana, cooking, horticulture, and bud tending; and manufactures and distributes specialty horse and pet grooming and topical applications. It has collaboration with IGXBio, Inc. to develop GenePro, a DNA-based immunotherapeutic drug; and a research collaboration agreement with Dana-Farber Cancer Institute, Inc. to develop and investigate the use of cannabinoids to cure various cancers, as well as with Stellenbosch University to treat chronic pelvic pain associated with pelvic inflammatory disease in women, chronic prostatitis in men, and other chronic pain associated with other indications. The company was formerly known as Gulf Onshore, Inc. and changed its name to Cannabis Science, Inc. in April 2009. The company was incorporated in 1996 and is based in Irvine, California. Cannabis Science, Inc. is a subsidiary of Weedmaps Media, Inc.

#6 - OrganiGram (CVE:OGI)

MarketBeat Followers: 584
Market Cap: C$536.91 million
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: C$6.25 (8.9% Upside)

OrganiGram Holdings Inc., through its subsidiaries, produces and sells medical marijuana to individuals and physicians in Canada. It offers marijuana plants, seeds, and cuttings; cannabis oil; and dried flower and cannabis. The company sells its products through phone and online store. It also operates healing centers that offer treatments for post-traumatic stress disorders, chronic pain, and trauma therapy. In addition, the company exports its products. OrganiGram Holdings Inc. was founded in 2013 and is based in Moncton, Canada.

#7 - United Cannabis (OTCMKTS:CNAB)

MarketBeat Followers: 401
Market Cap: $67.44 million
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

United Cannabis Corporation owns intellectual properties related to growth, production, manufacture, marketing, management, utilization, and distribution of medical marijuana and marijuana infused products in the United States. The company focuses on developing therapeutics, including Prana Bio Nutrient Medicinal products for supplement deficiencies related to the endocannabinoid system, including pain, neuropathy, arthritis, MS, IBS, autism, seizures, eczema, sleep, anxiety, head trauma, opioid dependency, and clinical endocannabinoid deficiencies; and Prana Aromatherapy Transdermal Roll-on line that provides targeted and large surface relief with combinations of aromatherapy. The company was formerly known as MySkin, Inc. and changed its name to United Cannabis Corporation in May 2014. United Cannabis Corporation was founded in 2007 and is based in Golden, Colorado.

#8 - Cannabis Sativa (OTCMKTS:CBDS)

MarketBeat Followers: 360
Market Cap: $100.69 million
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

Cannabis Sativa, Inc., through its subsidiaries, develops, manufactures, and sells herbal based skin care products in the United States. It offers Recover, a deep penetrating healing balm that reduces pain and inflammation for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant and moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. The company also engages in the research, development, and licensing of natural cannabis products comprising cannabis formulations, edibles, topicals, strains, recipes, and delivery systems. In addition, it operates iBudtender, an online portal that offers information and patient reviews on marijuana dispensaries, cannabis businesses, marijuana strains, edibles, and concentrates and products. The company markets and sells its products through sales professionals, as well as through retailers and distributors. Cannabis Sativa, Inc. is based in Mesquite, Nevada.

#9 - Medical Marijuana (OTCMKTS:MJNA)

MarketBeat Followers: 327
Market Cap: $325.25 million
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

Medical Marijuana, Inc., an investment holding company, operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries. The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry. It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products. In addition, the company provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics; and consulting and securities services to businesses and individuals in the legal cannabis industry. Further, it focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products. Medical Marijuana, Inc. was formerly known as Hemp Deposit Distribution Corp. and changed its name to Medical Marijuana, Inc. in March, 2011. The company was incorporated in 2003 and is headquartered in Poway, California.

#10 - Marijuana Company Of America (OTCMKTS:MCOA)

MarketBeat Followers: 270
Market Cap: $58.27 million
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

Marijuana Company of America, Inc., through its subsidiaries, develops, manufactures, and sells industrial hemp derived and non-psychoactive cannabinoids consumer products under the hempSMART brand in the United States and Canada. The company's principal products include hempSMART Brain, a personal care consumer product that supports brain wellness; hempSMART Pain, a capsule for the temporary relief of minor discomfort associated with physical activity; hempSMART Pain Cream, a wellness consumer product that reduces minor discomfort and promotes muscle relaxation on areas that it is applied; hempSMART Drops; and hempSMART Pet Drops for cats and dogs. It also provides financial accounting and bookkeeping services; and property management consulting services for companies associated with the cannabis industry. Marijuana Company of America, Inc. directly markets and sells its hempSMART products through its Website, as well as through an affiliate marketing program. The company was formerly known as Converge Global, Inc. and changed its name to Marijuana Company of America, Inc. in December 2015. Marijuana Company of America, Inc. was founded in 1985 and is headquartered in Escondido, California.

#11 - General Cannabis (OTCMKTS:CANN)

MarketBeat Followers: 267
Market Cap: $138.01 million
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

General Cannabis Corp provides products and services to the regulated cannabis industry in the United States. The company operates through four segments: Security and Cash Transportation Services (Security), Marketing Consulting and Apparel (Marketing), Operations Consulting and Products (Operations), and Finance and Real Estate (Finance). The Security segment advanced security services, including on-site professional and cash transport to licensed cannabis cultivators and retail shops, as well as security services to non-cannabis customers in the hospitality business. The Marketing segment provides designing, branding, and marketing strategy consulting services to the cannabis industry; and designs and sources client-specific apparel and products. This segment offers t-shirts, hats, hoodies, and accessories through an online shop, as well as cannabis retailers, and specialty t-shirt and gift shops. The Operations segment provides consulting services to the cannabis industry that comprise obtaining licenses, compliance, cultivation, retail operations, logistical support, facility design and construction, and expansion of existing operations. The Finance segment engages in the acquiring and leasing of cultivation space and related facilities to licensed marijuana growers and dispensary owners. This segment also offers shared office space, networking, and event services; direct term loans and revolving lines of credit; and customized finance, capital formation, and banking services. The company was formerly known as Advanced Cannabis Solutions, Inc. and changed its name to General Cannabis Corp in June 2015. General Cannabis Corp was incorporated in 2013 and is headquartered in Denver, Colorado.

#12 - MassRoots (OTCMKTS:MSRT)

MarketBeat Followers: 266
Market Cap: $38.62 million
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

MassRoots, Inc., together with its subsidiaries, operates a technology platform for the medical cannabis community in the United States. Its platform enables users to share their cannabis content, follow various dispensaries, and stay connected with the legalization movement; and its mobile apps enable consumers to make educated cannabis purchasing decisions through community-driven reviews. The company's network is accessible as a free mobile application through the iOS App Store, the Amazon App Store, and the Google Play Marketplace, as well as a Website at MassRoots.com. It also operates MassRoots for Business, an online portal for businesses to schedule posts and view analytics, as well as sells merchandise, including T-shirts, stickers, and jars. In addition, the company engages in developing Blockchain-based solutions for the cannabis industry. MassRoots, Inc. was founded in 2013 and is headquartered in Denver, Colorado.

	20 Stocks Wall Street Analysts Love the Most
	The Five Best Dow Jones Stocks to Buy Now
	15 Healthcare Stocks that Analysts Love
	Analysts Hate These 12 Stocks
	7 Best Stocks to Own Right Now
	15 Stocks that Insiders Love
	The 15 Best Growth Stocks You Can Buy Right Now